Skip to main content

Polar Capital Global Healthcare Select Fund

Polar Capital Global Healthcare Select Fund is an equity fund managed by Polar Capital in the Sektor – Helse category.

About this fund

Polar Capital Global Healthcare Select Fund sits in the Sektor – Helse peer group, where Polar Capital is the manager.

The fund: 12 years of track record, running since 2014 (share classes may be younger).

It is run by a team of 6.

It is measured against MSCI AC World Daily Total Return Net Health Care Index.

Manager
Polar Capital
Category
Sektor – Helse
Region
Global
SFDR
Article 8
ISIN
IE00BPRBXS98
Inception
2014-09-11
Benchmark
MSCI AC World Daily Total Return Net Health Care Index
AUM
266 m USD
Returns
YTD 4.6% · 1Y 8.7% · 3Y 8.9% · 5Y 9.0%

Portfolio managers

Actively managedEquityGlobal
YTD Return · NOK
+4,6 %from NAV
Calculated NOK return from EUR · EUR Class I Acc (NOK Calculated)

Computed from NAV history (price return, NOK, to 13 Nov 2026)

Last NAV 26,64 USD · 13 Nov 2026
Returns by period · NOK · net
ann. 3Y+
+4,6 %
YTD
+8,7 %
1y
+8,9 %
3y, annualised
+9,0 %
5y, annualised
Fund size
265,9 mill. USD
Total fund AUM
Ongoing charge
0,87 %
Annual · class I EUR Akk.
Performance fee
None
Stated by the manager
Annual cost on platforms
1,24 %
Class I EUR Akk. · 1 platform · net of platform rebate, incl. platform fee, excl. transaction costs
SFDR
Article 8
Sustainability
Launched
Sept 2014
ISIN IE00BPRBXQ74
BenchmarkMSCI ACWI Health Care · Net
About the fund
The fund

Polar Capital Global Healthcare Select Fund has a history going back to 2014. The management company, Polar Capital, is a specialist active manager in London, founded in 2001 and organised in relatively autonomous investment teams. The parent company is listed on AIM with a dispersed shareholder base.

Investment philosophy

The fund is weighted toward the largest health care companies, and its active share is somewhat higher than that of comparable funds.

The managers

James Douglas is listed as manager of the fund within Polar Capital's healthcare team. He joined the company in 2015, holds a PhD in medicinal chemistry and has a background in healthcare equity sales at Morgan Stanley, RBS and HSBC, research at UBS and consulting at EvaluatePharma. The team is led by its founder Gareth Powell in London, and David Pinniger and Deane Donnigan are also listed on the fund. The managers also run other Polar Capital healthcare funds.

The portfolio

The lasting top positions range from pharmaceuticals, such as Roche and AstraZeneca, to health insurance and services (UnitedHealth Group), medical devices (Abbott Laboratories) and research and analytics services (IQVIA Holdings, Agilent Technologies).

FundTelligence description · 18/10/2026

Portfolio managers

BR
Fund Manager
DA
Portfolio Manager
DA
Fund Manager
DE
Fund Manager
GA
Head of Healthcare
JA
Fund Manager

Position in the peer group

Sector Health Care Equities · 31 funds in the peer group. The number ranked and the date are stated per period. 12 of them converted to NOK.

11 of 22 funds ranked on a calculated return

#15/ 221 year
+8.72% NOK

as of 13 Nov 2026 · Converted from EUR to NOK

About the figures

9 of 31 funds in the group hold no figure for the date and are not counted. 1 funds with older figures: up to 5 business days.

#6/ 223 years (ann.)
+8.87% NOK

as of 13 Nov 2026 · Converted from EUR to NOK

About the figures

9 of 31 funds in the group hold no figure for the date and are not counted. 1 funds with older figures: up to 5 business days.

#2/ 225 years (ann.)
+8.99% NOK

as of 13 Nov 2026 · Converted from EUR to NOK

About the figures

9 of 31 funds in the group hold no figure for the date and are not counted. 1 funds with older figures: up to 5 business days.

Comparison basis

1 year

Comparison basis: Ranked among 22 of 31 funds · 9 left out (4 missing return, 2 return as of an earlier date, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026

3 years (ann.)

Comparison basis: Ranked among 22 of 31 funds · 9 left out (4 missing return, 2 return as of an earlier date, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026

5 years (ann.)

Comparison basis: Ranked among 22 of 31 funds · 9 left out (4 missing return, 2 return as of an earlier date, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026

The positions describe historical return and are not an assessment of the fund, nor investment advice. Past performance is no guarantee of future returns. A position applies only within its own peer group and cannot be compared with positions in other peer groups.

Fund data is taken from the managers’ own reports, otherwise computed from NAV history and, as a last resort, taken from distributor listings. Not official figures; verify with the fund provider before investing.

About our data